WANdisco Wins Three Year Contract With "Major" US Healthcare Firm

LONDON (Alliance News) - Big data and analytics firm WANdisco PLC said on Thursday it has won a ...

Alliance News 27 December, 2018 | 9:17AM
Email Form

LONDON (Alliance News) - Big data and analytics firm WANdisco PLC said on Thursday it has won a three-year contract with a "major" US managed healthcare company worth USD700,000 in royalties to the UK-listed firm.

The contract was secured via its original equipment manufacturer sales partnership with IBM Corp to deploy WANdisco's cloud product, WANdisco Fusion.

WANdisco said that it "significantly expanded" its relationship with IBM earlier this year, increasing its royalty percentage to 50%, from 30% previously, and agreeing a guaranteed annual royalty commitment.

The unnamed client has substantial data requirements, the company said, with over 45 million customers and 5,700 hospitals in its network. The US firm will be using Fusion on-premise for replication and disaster recovery. It is also the first sale of WANdisco's newly released Live backup solution, the company noted.

"We are continuing to gain strong traction in industries where critical data is needed to be continuously available. This is the second major healthcare deal we have agreed this month and follows our largest ever cloud deal valued at USD3 million. Our pipeline with IBM continues to build and our expanded relationship means we can efficiently and profitably service on-premise contracts," said Chief Executive & Chairman David Richards.

Shares in WANdisco were up 10% at 468.55 pence on Thursday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2018 Alliance News Limited. All Rights Reserved.

Email Form
Securities Mentioned in Article
Security Name Price Change (%) Morningstar
Rating
Wandisco PLC 628.00 GBX 1.95 -
About Author Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites